长药控股
(300391)
| 流通市值：19.34亿 | | | 总市值：19.34亿 |
| 流通股本：3.50亿 | | | 总股本：3.50亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 101,004,271.66 | 73,653,692.97 | 59,091,762.31 | 1,197,562,401.16 |
| 营业收入 | 101,004,271.66 | 73,653,692.97 | 59,091,762.31 | 1,197,562,401.16 |
| 二、营业总成本 | 230,247,560.76 | 164,292,501.69 | 89,749,307.79 | 1,181,599,101.7 |
| 营业成本 | 96,028,186.66 | 69,482,031.98 | 54,604,638.79 | 1,001,555,819.99 |
| 税金及附加 | 2,009,584.06 | 1,249,862.54 | 554,831.58 | 3,711,163.43 |
| 销售费用 | 13,041,596.22 | 9,403,184.58 | 5,103,682.48 | 23,589,465.74 |
| 管理费用 | 52,775,025.94 | 33,608,935.27 | 16,085,180.97 | 84,113,854.5 |
| 研发费用 | 3,328,745.66 | 2,205,310.31 | 978,777.88 | 7,660,845.44 |
| 财务费用 | 63,064,422.22 | 48,343,177.01 | 12,422,196.09 | 60,967,952.6 |
| 其中:利息费用 | 61,345,196.06 | 48,874,983.65 | 12,788,662.59 | 61,314,836.15 |
| 其中:利息收入 | 584,041.47 | 44,262.3 | 213,874.37 | 97,148.46 |
| 加:公允价值变动收益 | - | - | - | 67,630,273.95 |
| 资产处置收益 | -495,306.54 | -520,863.55 | - | 78,554.78 |
| 资产减值损失(新) | -27,392,907.64 | -27,294,182.41 | - | -559,696,362.87 |
| 信用减值损失(新) | -120,018,439.53 | -120,252,252.85 | -47,021,483.23 | -195,895,254.67 |
| 其他收益 | 520,871.33 | 346,793.85 | 245,692.78 | 2,210,108.67 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -276,629,071.48 | -238,359,313.68 | -77,433,335.93 | -669,709,380.68 |
| 加:营业外收入 | 30,216.67 | 8,064.67 | 5,152.06 | 764,071.75 |
| 减:营业外支出 | 3,499,794.72 | 3,353,913.44 | 3,692,085.55 | 12,064,823.35 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -280,098,649.53 | -241,705,162.45 | -81,120,269.42 | -681,010,132.28 |
| 减:所得税费用 | 6,526.35 | - | - | 26,324,373.35 |
| 六、净利润 | -280,105,175.88 | -241,705,162.45 | -81,120,269.42 | -707,334,505.63 |
| 持续经营净利润 | -280,105,175.88 | -241,705,162.45 | -81,120,269.42 | -707,334,505.63 |
| 归属于母公司股东的净利润 | -180,970,726.99 | -152,573,059.07 | -47,505,902.27 | -605,653,315 |
| 少数股东损益 | -99,134,448.89 | -89,132,103.38 | -33,614,367.15 | -101,681,190.63 |
| (一)基本每股收益 | -0.52 | -0.44 | -0.14 | -1.73 |
| (二)稀释每股收益 | -0.52 | -0.44 | -0.14 | -1.73 |
| 九、综合收益总额 | -280,105,175.88 | -241,705,162.45 | -81,120,269.42 | -707,334,505.63 |
| 归属于母公司股东的综合收益总额 | -180,970,726.99 | -152,573,059.07 | -47,505,902.27 | -605,653,315 |
| 归属于少数股东的综合收益总额 | -99,134,448.89 | -89,132,103.38 | -33,614,367.15 | -101,681,190.63 |
| 公告日期 | 2024-10-30 | 2024-08-30 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 带强调事项段的无保留意见 |